MetaCap

InMode Ltd. Company Profile

NASDAQ: INMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

14.19+0.105 (+0.75%)

Market open · Delayed 15 min · as of Oct 9, 2:37 PM ET

InMode at a glance

InMode Ltd. (NASDAQ: INMD) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company in the Health Care sector headquartered in Yokne'am, Israel. InMode is led by Mr. Moshe Mizrahy and employs about 660 people. The company's shares have traded publicly since 2019.

At a market capitalization of $805.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001742692, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does InMode do?

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Business description based on the company's public filings.

Company information

Legal name
InMode Ltd.
Ticker
NASDAQ: INMD
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Moshe Mizrahy
Employees
660
Headquarters
Tavor Building, Yokne'am, Israel
Phone
972 4 909 6313
IPO year
2019
Market cap
$805.31M
SEC CIK
0001742692

Companies similar to InMode

INMD peer companies
CompanyPrice% ChgMarket capCompare
CBLLCeriBell Inc.23.06-0.41%$884.81Mvs INMD
CVCapsoVision Inc.6.58-0.68%$349.86Mvs INMD
CNMDCONMED Corporation44.25-1.91%$1.33Bvs INMD
ELMDElectromed Inc.27.64-0.58%$229.06Mvs INMD
FOCLEDAP TMS S.A. ADR4.18+1.21%$197.13Mvs INMD
HSDTSolana Company Class A2.40+0.84%$156.25Mvs INMD
VANIVivani Medical Inc.1.230.00%$110.95Mvs INMD
STXSStereotaxis Inc.1.10-0.89%$110.23Mvs INMD

Related